Kidney Estimate Gaps Linked to Higher Death Risk

In a study of over 800,000 outpatients, large gaps between two kidney blood tests were tied to higher rates of death and heart failure.

Updated on Nov. 20, 2026 in Diseases — General

Photograph of plain glass vials of pale amber and blue-green liquid in a wooden rack on a white laboratory bench under soft window light.
A meta-analysis of 821,327 outpatients found that large gaps between two kidney blood tests were linked to higher rates of death and heart failure. AI Illustration. Upload story photo >

A meta-analysis of 821,327 outpatients across 23 cohorts found that when cystatin C-based kidney function estimates were at least 30% lower than creatinine-based estimates, participants had higher rates of death and heart failure. The analysis was led by the Chronic Kidney Disease Prognosis Consortium and was published with data from hospitalized patients as well.

Why it matters

Estimated kidney function is often calculated from creatinine alone, but cystatin C offers a second measure, and disagreement between the two may flag people whose risk is underestimated. For adults with chronic kidney disease or cardiovascular concerns, the finding suggests that discordant results could matter for how risk is assessed in clinical care.

The study pooled individual-level data from 23 outpatient cohorts and 2 inpatient cohorts, with all participants having both creatinine and cystatin C measured. Outpatients averaged 11 years of follow-up, and the findings are associational, adjusted for demographics, comorbidities, body mass index, creatinine-based category and albuminuria.

The players

Chronic Kidney Disease Prognosis Consortium

An international research collaboration that pools individual participant data to study the prognosis of chronic kidney disease.

UK Biobank

A large British cohort study that has collected health, genetic and biological data from hundreds of thousands of adults for long-term disease research.

The details

Creatinine, a waste product from muscle, is the standard marker used to estimate kidney filtration, while cystatin C is a protein filtered by the kidneys that is less influenced by muscle mass. When the two estimates diverge sharply, with cystatin C-based estimates at least 30% lower, the gap may reflect factors that creatinine alone does not capture. The analysis adjusted for several of these factors, but the mechanism linking the gap to worse outcomes is not established by the data.

Timeline

  1. Outpatient outcomes were tracked over a mean follow-up of 11 years across the cohorts.

Health Landscape

Kidney function has long been estimated from creatinine, and the pooled work of the Chronic Kidney Disease Prognosis Consortium has been used to refine how those estimates predict outcomes. This meta-analysis places cystatin C alongside creatinine as a potential signal in population-level risk assessment, though the clinical standard for combining the two is still being debated.

If you have been told your kidney function is estimated from creatinine alone, it may be worth asking your doctor whether a cystatin C test is relevant to your situation. The finding is population-level and observational, so it should be discussed with a clinician rather than acted on alone.

The takeaway

Kidney function estimates that disagree substantially between creatinine and cystatin C may carry added information about risk. Ask your physician whether your kidney tests are interpreted alongside each other, especially if you have heart or kidney concerns.

Further reading

For broader context on conditions affecting the kidneys and heart, see Diseases — General.

Source note: This article includes information reported by Ajmc.